Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group (Q34546186)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group |
scientific article |
Statements
1 reference
Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group (English)
1 reference
M Debiec-Rychter
1 reference
B Wasag
1 reference
H Dumez
1 reference
I Judson
1 reference
J Verweij
1 reference
M Brown
1 reference
S Dimitrijevic
1 reference
R Sciot
1 reference
M Stul
1 reference
H Vranck
1 reference
M Scurr
1 reference
A Hagemeijer
1 reference
M van Glabbeke
1 reference
A T van Oosterom
1 reference
EORTC Soft Tissue and Bone Sarcoma Group
1 reference
1 reference
Identifiers
1 reference